The current approach to ulcerative colitis begins with clinical and endoscopic evaluations and the assessment of disease severity. Depending on the diagnostic findings, treatment options range from traditional agents such as mesalamine to tumor necrosis factor inhibitors and newer, more targeted medications. However, experts say that the newer agents need to be used earlier in the course of disease for optimal outcomes.
The following brief quiz tests one aspect of each article from the three-part Clinical Challenge series on ulcerative colitis, looking at diagnosis, treatment, and long-term concerns. Correct answers and explanations will appear after completing the quiz.
Last Updated June 12, 2020